Published • loading... • Updated
HIO tells doctors to switch diabetes patients to Ozempic as stocks run out
Summary by philenews.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
HIO tells doctors to switch diabetes patients to Ozempic as stocks run out
The Health Insurance Organisation (HIO) has announced that stocks of Victoza, a widely prescribed injectable diabetes medication, have run out, and is urgently calling on doctors to switch all affected patients to Ozempic ahead of a June 1 implementation date. In a notice sent to general practitioners, endocrinologists, pathologists, geriatricians and private pharmacies, the HIO said patients currently on Victoza (liraglutide) must be transferre…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
